Commercialisation of Remote-I for general practice screening of DR nears

The availability of the CSIRO's low-cost retinal imaging technology Remote-I for use by GPs to screen for diabetic retinopathy (DR) is one step closer following the successful conclusion of a trial at a GP superclinic in Perth.

CSIRO has been conducting the trial with the GP Superclinic at Midland Railway Workshops in Perth since last November, screening 187 diabetic patients by taking high resolution images and analysing them with CSIRO's Dr Grader software.

The technology has been licensed to US telehealth firm TeleMedC, which plans to make it commercially available and install it in a further 20 practices in WA over the next few months, before expanding across Australia.

Posted in Australian eHealth

Tags: CSIRO, AeHRC, Remote-I

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2018 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.